PALATIN TECHNOLOGIES, INC. Income (Loss) from Continuing Operations before Income Taxes, Domestic
PALATIN TECHNOLOGIES, INC. (PTN) reported Income (Loss) from Continuing Operations before Income Taxes, Domestic of -$7.30 million for the 3-month period ending 2020-06-30, per its 10-K filed 2020-09-25.
Discontinued › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic · last filed 2020-09-25
- PALATIN TECHNOLOGIES, INC. income (loss) from continuing operations before income taxes, domestic for the quarter ending 2020-06-30 was -$7.30M, a 113.98% decline year-over-year.
- PALATIN TECHNOLOGIES, INC. income (loss) from continuing operations before income taxes, domestic for the quarter ending 2020-03-31 was -$5.38M.
- PALATIN TECHNOLOGIES, INC. income (loss) from continuing operations before income taxes, domestic for the quarter ending 2019-12-31 was -$5.24M.
- PALATIN TECHNOLOGIES, INC. income (loss) from continuing operations before income taxes, domestic for the quarter ending 2019-09-30 was -$4.50M.
- PALATIN TECHNOLOGIES, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2020 was -$22.43M, a 162.69% decline from fiscal 2019.
- PALATIN TECHNOLOGIES, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2019 was $35.77M, a 44.33% increase from fiscal 2018.
- PALATIN TECHNOLOGIES, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2018 was $24.79M, a 0.00% change from fiscal 2017.
- PALATIN TECHNOLOGIES, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2017 was $24.79M.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Domestic 3 month | Income (Loss) from Continuing Operations before Income Taxes, Domestic 3 month as first filed | Income (Loss) from Continuing Operations before Income Taxes, Domestic 6 month | Income (Loss) from Continuing Operations before Income Taxes, Domestic 9 month | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month as first filed |
|---|---|---|---|---|---|---|
| 2020-06-30 | -$7.30M 10-K · filed 2020-09-25 | -$12.68M derived: sum of 2 quarters · filed 2020-09-25 | -$17.93M derived: sum of 3 quarters · filed 2020-09-25 | -$22.43M 10-K · filed 2020-09-25 | ||
| 2020-03-31 | -$5.38M 10-K · filed 2020-09-25 | -$10.63M derived: sum of 2 quarters · filed 2020-09-25 | -$15.13M derived: sum of 3 quarters · filed 2020-09-25 | $37.10M derived: sum of 4 quarters · filed 2020-09-25 | ||
| 2019-12-31 | -$5.24M 10-K · filed 2020-09-25 | -$9.74M derived: sum of 2 quarters · filed 2020-09-25 | $42.48M derived: sum of 3 quarters · filed 2020-09-25 | $36.75M derived: sum of 4 quarters · filed 2020-09-25 | ||
| 2019-09-30 | -$4.50M 10-K · filed 2020-09-25 | $47.72M derived: sum of 2 quarters · filed 2020-09-25 | $42.00M derived: sum of 3 quarters · filed 2020-09-25 | $36.95M derived: sum of 4 quarters · filed 2020-09-25 | ||
| 2019-06-30 | $52.22M 10-K · filed 2020-09-25 | $52.22K 10-K · filed 2019-09-12 | $46.50M derived: sum of 2 quarters · filed 2020-09-25 | $41.45M derived: sum of 3 quarters · filed 2020-09-25 | $35.77M 10-K · filed 2020-09-25 | |
| 2019-03-31 | -$5.73M 10-K · filed 2020-09-25 | -$5.73K 10-K · filed 2019-09-12 | -$10.77M derived: sum of 2 quarters · filed 2020-09-25 | -$16.45M derived: sum of 3 quarters · filed 2020-09-25 | -$16.44M derived: sum of 4 quarters · filed 2020-09-25 | |
| 2018-12-31 | -$5.04M 10-K · filed 2020-09-25 | -$5.04K 10-K · filed 2019-09-12 | -$10.72M derived: sum of 2 quarters · filed 2020-09-25 | -$10.71M derived: sum of 3 quarters · filed 2020-09-25 | -$10.71M derived: sum of 4 quarters · filed 2020-09-25 | |
| 2018-09-30 | -$5.68M 10-K · filed 2020-09-25 | -$5.68K 10-K · filed 2019-09-12 | -$5.67M derived: sum of 2 quarters · filed 2020-09-25 | -$5.67M derived: sum of 3 quarters · filed 2020-09-25 | -$5.67M derived: sum of 4 quarters · filed 2020-09-25 | |
| 2018-06-30 | $12.08K 10-K · filed 2019-09-12 | $11.32K derived: sum of 2 quarters · filed 2019-09-12 | $13.96K derived: sum of 3 quarters · filed 2019-09-12 | $24.79M 10-K · filed 2019-09-12 | ||
| 2018-03-31 | -$758.00 10-K · filed 2019-09-12 | $1.87K derived: sum of 2 quarters · filed 2019-09-12 | $12.70K derived: sum of 3 quarters · filed 2019-09-12 | $26.52K derived: sum of 4 quarters · filed 2019-09-12 | ||
| 2017-12-31 | $2.63K 10-K · filed 2019-09-12 | $13.46K derived: sum of 2 quarters · filed 2019-09-12 | $27.27K derived: sum of 3 quarters · filed 2019-09-12 | $23.71K derived: sum of 4 quarters · filed 2019-09-12 | ||
| 2017-09-30 | $10.83K 10-K · filed 2019-09-12 | $24.64K derived: sum of 2 quarters · filed 2019-09-12 | $21.08K derived: sum of 3 quarters · filed 2019-09-12 | $11.05K derived: sum of 4 quarters · filed 2019-09-12 | ||
| 2017-06-30 | $13.81K 10-K · filed 2018-09-13 | $10.25K derived: sum of 2 quarters · filed 2018-09-13 | $222.00 derived: sum of 3 quarters · filed 2018-09-13 | $24.79M 10-K · filed 2020-09-25 | -$12.83M 10-K · filed 2017-09-25 | |
| 2017-03-31 | -$3.56K 10-K · filed 2018-09-13 | -$13.59K derived: sum of 2 quarters · filed 2018-09-13 | -$26.65K derived: sum of 3 quarters · filed 2018-09-13 | -$40.00K derived: sum of 4 quarters · filed 2018-09-13 | ||
| 2016-12-31 | -$10.03K 10-K · filed 2018-09-13 | -$23.08K derived: sum of 2 quarters · filed 2018-09-13 | -$36.44K derived: sum of 3 quarters · filed 2018-09-13 | -$49.13K derived: sum of 4 quarters · filed 2018-09-13 | ||
| 2016-09-30 | -$13.05K 10-K · filed 2018-09-13 | -$26.41K derived: sum of 2 quarters · filed 2018-09-13 | -$39.11K derived: sum of 3 quarters · filed 2018-09-13 | -$52.36K derived: sum of 4 quarters · filed 2018-09-13 | ||
| 2016-06-30 | -$13.36K 10-K · filed 2017-09-25 | -$26.05K derived: sum of 2 quarters · filed 2017-09-25 | -$39.30K derived: sum of 3 quarters · filed 2017-09-25 | -$51.71M 10-K · filed 2018-09-13 | ||
| 2016-03-31 | -$12.70K 10-K · filed 2017-09-25 | -$25.95K derived: sum of 2 quarters · filed 2017-09-25 | -$38.36K derived: sum of 3 quarters · filed 2017-09-25 | -$50.45K derived: sum of 4 quarters · filed 2017-09-25 | ||
| 2015-12-31 | -$13.25K 10-K · filed 2017-09-25 | -$25.66K derived: sum of 2 quarters · filed 2017-09-25 | -$37.75K derived: sum of 3 quarters · filed 2017-09-25 | -$46.90K derived: sum of 4 quarters · filed 2017-09-25 | ||
| 2015-09-30 | -$12.41K 10-K · filed 2017-09-25 | -$24.50K derived: sum of 2 quarters · filed 2017-09-25 | -$33.65K derived: sum of 3 quarters · filed 2017-09-25 | -$31.40K derived: sum of 4 quarters · filed 2017-09-25 | ||
| 2015-06-30 | -$12.09K 10-K · filed 2016-09-19 | -$21.24K derived: sum of 2 quarters · filed 2016-09-19 | -$18.99K derived: sum of 3 quarters · filed 2016-09-19 | -$18.20M 10-K · filed 2017-09-25 | ||
| 2015-03-31 | -$9.15K 10-K · filed 2016-09-19 | -$6.91K derived: sum of 2 quarters · filed 2016-09-19 | -$6.11K derived: sum of 3 quarters · filed 2016-09-19 | -$10.43K derived: sum of 4 quarters · filed 2016-09-19 | ||
| 2014-12-31 | $2.25K 10-K · filed 2016-09-19 | $3.04K derived: sum of 2 quarters · filed 2016-09-19 | -$1.28K derived: sum of 3 quarters · filed 2016-09-19 | -$4.64K derived: sum of 4 quarters · filed 2016-09-19 | ||
| 2014-09-30 | $795.00 10-K · filed 2016-09-19 | -$3.52K derived: sum of 2 quarters · filed 2016-09-19 | -$6.88K derived: sum of 3 quarters · filed 2016-09-19 | -$10.49K derived: sum of 4 quarters · filed 2016-09-19 | ||
| 2014-06-30 | -$4.32K 10-K · filed 2015-09-18 | -$4.32M 10-K · filed 2014-09-12 | -$7.68K derived: sum of 2 quarters · filed 2015-09-18 | -$11.29K derived: sum of 3 quarters · filed 2015-09-18 | -$15.77M 10-K · filed 2016-09-19 | |
| 2014-03-31 | -$3.36K 10-K · filed 2015-09-18 | -$3.36M 10-Q · filed 2014-05-12 | -$6.97K derived: sum of 2 quarters · filed 2015-09-18 | -$11.46M 10-Q · filed 2014-05-12 | -$4.73M derived: sum of 4 quarters · filed 2015-09-18 | |
| 2013-12-31 | -$3.61K 10-K · filed 2015-09-18 | -$3.61M 10-Q · filed 2014-02-14 | -$8.10M 10-Q · filed 2014-02-14 | -$4.73M derived: sum of 3 quarters · filed 2015-09-18 | -$8.74M derived: sum of 4 quarters · filed 2015-09-18 | |
| 2013-09-30 | -$4.49K 10-K · filed 2015-09-18 | -$4.49M 10-K · filed 2014-09-12 | -$4.72M derived: sum of 2 quarters · filed 2015-09-18 | -$8.74M derived: sum of 3 quarters · filed 2015-09-18 | -$12.17M derived: sum of 4 quarters · filed 2015-09-18 | |
| 2013-06-30 | -$4.72M 10-K · filed 2014-09-12 | -$8.73M derived: sum of 2 quarters · filed 2014-09-12 | -$12.16M derived: sum of 3 quarters · filed 2014-09-12 | -$22.62M 10-K · filed 2015-09-18 | ||
| 2013-03-31 | -$4.01M 10-K · filed 2014-09-12 | -$4.02M 10-Q · filed 2013-05-13 | -$7.44M derived: sum of 2 quarters · filed 2014-09-12 | -$17.90M 10-Q · filed 2014-05-12 | -$23.15M derived: sum of 4 quarters · filed 2014-09-12 | |
| 2012-12-31 | -$3.43M 10-K · filed 2014-09-12 | -$3.43M 10-Q · filed 2013-02-13 | -$13.88M 10-Q · filed 2014-02-14 | -$19.14M derived: sum of 3 quarters · filed 2014-09-12 | -$25.16M derived: sum of 4 quarters · filed 2014-09-12 | |
| 2012-09-30 | -$10.45M 10-K · filed 2014-09-12 | -$15.71M derived: sum of 2 quarters · filed 2014-09-12 | -$21.73M derived: sum of 3 quarters · filed 2014-09-12 | -$25.42M derived: sum of 4 quarters · filed 2014-09-12 | ||
| 2012-06-30 | -$5.25M 10-K · filed 2013-09-27 | -$11.27M derived: sum of 2 quarters · filed 2013-09-27 | -$14.97M derived: sum of 3 quarters · filed 2013-09-27 | -$18.32M 10-K · filed 2014-09-12 | ||
| 2012-03-31 | -$6.02M 10-K · filed 2013-09-27 | -$6.02M 10-Q · filed 2013-05-13 | -$9.71M derived: sum of 2 quarters · filed 2013-09-27 | -$13.07M 10-Q · filed 2013-05-13 | ||
| 2011-12-31 | -$3.69M 10-K · filed 2013-09-27 | -$3.69M 10-Q · filed 2013-02-13 | -$7.05M 10-Q · filed 2013-02-13 | |||
| 2011-09-30 | -$3.35M 10-K · filed 2013-09-27 | |||||
| 2011-06-30 | -$13.45M 10-K · filed 2013-09-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |